These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir. Waters MD; Warren S; Hughes C; Lewis P; Zhang F Environ Mol Mutagen; 2022 Jan; 63(1):37-63. PubMed ID: 35023215 [TBL] [Abstract][Full Text] [Related]
4. Uridine-cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine. Xu Z; Flensburg C; Bilardi RA; Majewski IJ Nucleic Acids Res; 2023 Dec; 51(22):12031-12042. PubMed ID: 37953355 [TBL] [Abstract][Full Text] [Related]
5. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template. Gordon CJ; Tchesnokov EP; Schinazi RF; Götte M J Biol Chem; 2021 Jul; 297(1):100770. PubMed ID: 33989635 [TBL] [Abstract][Full Text] [Related]
10. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity. Yip AJW; Low ZY; Chow VTK; Lal SK Viruses; 2022 Jun; 14(6):. PubMed ID: 35746815 [TBL] [Abstract][Full Text] [Related]
11. Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity. Hadj Hassine I; Ben M'hadheb M; Menéndez-Arias L Viruses; 2022 Apr; 14(4):. PubMed ID: 35458571 [TBL] [Abstract][Full Text] [Related]
12. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sheahan TP; Sims AC; Zhou S; Graham RL; Pruijssers AJ; Agostini ML; Leist SR; Schäfer A; Dinnon KH; Stevens LJ; Chappell JD; Lu X; Hughes TM; George AS; Hill CS; Montgomery SA; Brown AJ; Bluemling GR; Natchus MG; Saindane M; Kolykhalov AA; Painter G; Harcourt J; Tamin A; Thornburg NJ; Swanstrom R; Denison MR; Baric RS Sci Transl Med; 2020 Apr; 12(541):. PubMed ID: 32253226 [TBL] [Abstract][Full Text] [Related]
13. A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes. Sanderson T; Hisner R; Donovan-Banfield I; Hartman H; Løchen A; Peacock TP; Ruis C Nature; 2023 Nov; 623(7987):594-600. PubMed ID: 37748513 [TBL] [Abstract][Full Text] [Related]
14. New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses. Siniavin AE; Gushchin VA; Shastina NS; Darnotuk ES; Luyksaar SI; Russu LI; Inshakova AM; Shidlovskaya EV; Vasina DV; Kuznetsova NA; Savina DM; Zorkov ID; Dolzhikova IV; Sheremet AB; Logunov DY; Zigangirova NA; Gintsburg AL Antiviral Res; 2024 May; 225():105871. PubMed ID: 38555022 [TBL] [Abstract][Full Text] [Related]
15. Molnupiravir: Mechanism of action, clinical, and translational science. Maas BM; Strizki J; Miller RR; Kumar S; Brown M; Johnson MG; Cheng M; De Anda C; Rizk ML; Stone JA Clin Transl Sci; 2024 Feb; 17(2):e13732. PubMed ID: 38593352 [TBL] [Abstract][Full Text] [Related]
17. Oxidative DNA Damage by N4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir. Kobayashi H; Mori Y; Ahmed S; Hirao Y; Kato S; Kawanishi S; Murata M; Oikawa S J Infect Dis; 2023 Apr; 227(9):1068-1072. PubMed ID: 36461940 [TBL] [Abstract][Full Text] [Related]
18. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Crotty S; Maag D; Arnold JJ; Zhong W; Lau JY; Hong Z; Andino R; Cameron CE Nat Med; 2000 Dec; 6(12):1375-9. PubMed ID: 11100123 [TBL] [Abstract][Full Text] [Related]
19. Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses. Wang Y; Li P; Solanki K; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q Virology; 2021 Dec; 564():33-38. PubMed ID: 34619630 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry. Urbanowicz K; Opielka M; Stegmann KM; Dickmanns A; Dobbelstein M; Peters GJ; Smoleński RT Nucleosides Nucleotides Nucleic Acids; 2024; 43(8):813-821. PubMed ID: 38741480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]